Edison healthcare quarterly: Immunotherapy takes centre stage
A few years ago, cancer immunotherapy papers that made it into ASCO would be scheduled for presentation on the last half day of conference when most attendees were already heading out of town. Not so this year, when immunotherapies were featured in the prime Sunday and Monday sessions. Moreover, this year additional sessions were dedicated to this topic at ASCO, such has been its change of fortune. This reflects the progression the field has made in the last few years as well as the importance this type of therapy is set to play in cancer management. In this report we provide an overview of the immunotherapy field.
Download PDF